思创医惠
(300078)
| 流通市值：40.86亿 | | | 总市值：41.03亿 |
| 流通股本：11.13亿 | | | 总股本：11.18亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 439,934,835.34 | 415,200,644.88 | 385,016,286.89 | 516,095,258.82 |
| 结算备付金 | - | 0 | - | - |
| 拆出资金 | - | 0 | - | - |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 354,085,623.95 | 395,770,579.02 | 431,859,925.12 | 523,833,833.5 |
| 其中：应收票据 | 1,051,740.79 | 450,900 | - | - |
| 应收账款 | 353,033,883.16 | 395,319,679.02 | 431,859,925.12 | 523,833,833.5 |
| 应收款项融资 | - | 0 | 230,680 | 12,680 |
| 预付款项 | 11,163,139.31 | 11,725,710.9 | 14,679,615.36 | 12,998,108.46 |
| 应收保费 | - | 0 | - | - |
| 应收分保账款 | - | 0 | - | - |
| 应收分保合同准备金 | - | 0 | - | - |
| 其他应收款合计 | 66,222,604.4 | 42,992,233.94 | 44,754,432.42 | 48,512,518.37 |
| 存货 | 191,570,172.99 | 176,396,663.36 | 221,632,485.76 | 215,669,069.36 |
| 合同资产 | 38,468,191.73 | 40,959,637.22 | 57,244,976.02 | 57,989,526.04 |
| 一年内到期的非流动资产 | - | 0 | - | - |
| 其他流动资产 | 6,255,202.55 | 2,089,149.96 | 4,872,040.67 | 3,881,999.93 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,111,574,007.23 | 1,290,839,328.94 | 1,415,933,655.12 | 1,684,018,665.73 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | - | - |
| 债权投资 | - | 0 | - | - |
| 其他债权投资 | - | 0 | - | - |
| 长期应收款 | 19,927,740.15 | 19,927,740.15 | 23,835,478.14 | 23,835,478.14 |
| 长期股权投资 | 103,848,078.6 | 104,540,469.97 | 138,887,012.35 | 137,860,015.04 |
| 其他权益工具投资 | - | 0 | - | - |
| 其他非流动金融资产 | 77,127,351.36 | 77,127,351.36 | 84,652,240.21 | 84,652,240.21 |
| 投资性房地产 | 2,857,182.97 | 292,351,288.6 | 294,745,425.8 | 318,389,655.54 |
| 固定资产 | 144,872,928.7 | 346,767,620.14 | 362,724,794.85 | 374,022,932.19 |
| 在建工程 | 879,115.05 | 879,115.05 | - | - |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 1,995,115.37 | 2,303,596.55 | 2,618,877.51 | 3,487,281.41 |
| 无形资产 | 35,227,896.8 | 45,731,505.44 | 59,189,419.92 | 67,255,106.51 |
| 开发支出 | - | 0 | - | - |
| 商誉 | - | 0 | 9,463,602.27 | 9,463,602.27 |
| 长期待摊费用 | 3,847,557.87 | 4,608,687.02 | 2,417,484.13 | 1,653,391.05 |
| 递延所得税资产 | 4,718,565.09 | 4,718,565.09 | 2,265,800.16 | 2,265,800.16 |
| 其他非流动资产 | - | 0 | 71,400 | 71,400 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 395,301,531.96 | 898,955,939.37 | 980,871,535.34 | 1,022,956,902.52 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,506,875,539.19 | 2,189,795,268.31 | 2,396,805,190.46 | 2,706,975,568.25 |
| 流动负债: | | | | |
| 短期借款 | - | 0 | 135,376,666.66 | 297,509,342.53 |
| 向中央银行借款 | - | 0 | - | - |
| 吸收存款及同业存放 | - | 0 | - | - |
| 拆入资金 | - | 0 | - | - |
| 交易性金融负债 | - | 0 | - | - |
| 衍生金融负债 | - | 0 | - | - |
| 应付票据及应付账款 | 299,394,087.15 | 319,186,637.94 | 261,966,627.09 | 323,239,339.79 |
| 其中：应付票据 | - | 0 | - | 10,000,000 |
| 应付账款 | 299,394,087.15 | 319,186,637.94 | 261,966,627.09 | 313,239,339.79 |
| 预收款项 | - | 0 | - | - |
| 合同负债 | 64,208,706.56 | 56,886,458.05 | 80,706,287.45 | 73,058,902.88 |
| 卖出回购金融资产款 | - | 0 | - | - |
| 应付手续费及佣金 | - | 0 | - | - |
| 应付职工薪酬 | 29,946,921.03 | 31,335,368.33 | 35,902,972.3 | 45,833,295.12 |
| 应交税费 | 44,303,063.09 | 36,774,224.89 | 46,357,686.23 | 48,122,340.88 |
| 其他应付款合计 | 157,151,801.89 | 631,253,933.93 | 48,971,347.19 | 576,286,097.11 |
| 应付分保账款 | - | 0 | - | - |
| 保险合同准备金 | - | 0 | - | - |
| 代理买卖证券款 | - | 0 | - | - |
| 代理承销证券款 | - | 0 | - | - |
| 一年内到期的非流动负债 | 1,370,585.58 | 265,345,316.99 | 36,630,644.51 | 60,098,580.11 |
| 其他流动负债 | 62,950,874.19 | 61,801,417.21 | 146,532,105.04 | 145,478,893.39 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 659,326,039.49 | 1,402,583,357.34 | 792,444,336.47 | 1,569,626,791.81 |
| 非流动负债: | | | | |
| 长期借款 | - | 0 | 263,008,341.71 | 263,070,147.96 |
| 应付债券 | - | 0 | 209,282,559.26 | 470,374,455.78 |
| 优先股 | - | 0 | - | - |
| 永续债 | - | 0 | - | - |
| 租赁负债 | 1,018,447.5 | 1,018,447.5 | 2,140,374.93 | 2,140,374.93 |
| 长期应付款 | 237,734,980.94 | 153,736,323.48 | 523,489,150.84 | - |
| 长期应付职工薪酬 | - | 0 | - | - |
| 预计负债 | 43,079,860.01 | 43,079,860.01 | 527,833.33 | 527,833.33 |
| 递延收益 | - | 0 | - | - |
| 递延所得税负债 | - | 0 | - | - |
| 其他非流动负债 | 514,012.58 | 514,012.58 | 514,012.58 | 514,012.58 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 282,347,301.03 | 198,348,643.57 | 998,962,272.65 | 736,626,824.58 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 941,673,340.52 | 1,600,932,000.91 | 1,791,406,609.12 | 2,306,253,616.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,117,872,230 | 1,125,092,230 | 1,029,031,270 | 905,881,745 |
| 其他权益工具 | - | 0 | 60,383,988.37 | 137,108,347.49 |
| 资本公积 | 1,787,458,880.56 | 1,830,213,446.44 | 1,659,397,627.73 | 1,441,541,723.79 |
| 减:库存股 | - | 49,974,565.88 | 49,974,565.88 | 49,974,565.88 |
| 其他综合收益 | -12,637,014.24 | -7,432,479.9 | -6,453,996.69 | -4,139,824.13 |
| 专项储备 | - | 0 | - | - |
| 盈余公积 | 72,600,033.72 | 72,600,033.72 | 72,600,033.72 | 72,600,033.72 |
| 一般风险准备 | - | 0 | - | - |
| 未分配利润 | -2,410,268,730.54 | -2,390,709,729.77 | -2,172,839,970.7 | -2,112,044,155.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 555,025,399.5 | 579,788,934.61 | 592,144,386.55 | 390,973,304.2 |
| 少数股东权益 | 10,176,799.17 | 9,074,332.79 | 13,254,194.79 | 9,748,647.66 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 565,202,198.67 | 588,863,267.4 | 605,398,581.34 | 400,721,951.86 |
| 负债和股东权益合计 | 1,506,875,539.19 | 2,189,795,268.31 | 2,396,805,190.46 | 2,706,975,568.25 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 保留意见 | | |